Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Miniaturized Device Monitors Blood Metabolites in ICU

By LabMedica International staff writers
Posted on 03 Nov 2015
A miniaturized microfluidic device could allow healthcare workers to monitor key metabolites in real time in intensive care units (ICUs).

Developed by researchers at Ecole Polytechnique Fédérale de Lausanne (EPFL; Switzerland) the device consists of a little black box with embedded biosensors that is attached to a patient’s drainage tube. The prototype device, fabricated using a three dimensional (3-D) printer, can currently monitor real time levels of glucose, lactate, bilirubin, calcium, and potassium. Eventually, according to the researchers, up to 40 different molecules could be monitored using the device, thus reducing the need for additional diagnostic devices.

The prototype includes a fully integrated hardware platform on a printed circuit board (PCB) that connects the biosensors to a read-out on the front end, as well as wireless connectivity via a Bluetooth module for data transmission to a mobile Android interface for visualization. Preliminary in vitro tests on calibration for the five key metabolites of interest were conducted successfully on rodents. A study describing the device and the results was presented at the annual Biomedical Circuits and Systems Conference (BioCAS), held during October 2015 in Atlanta (GA, USA).

“We embedded biosensors in it to measure several different substances in the blood or blood serum along with an array of electronics to transmit the results in real time to a tablet via Bluetooth,” said study presenter Sandro Carrara, PhD, a scientist at the EPFL integrated systems laboratory (LSI). “Nowadays, several of these levels are measured periodically. But in some cases, any change in level calls for an immediate response, something that is not possible with the existing systems.”

Microfluidics intersects engineering, physics, chemistry, biochemistry, nanotechnology, and biotechnology, in order to process low volumes of fluid for multiplexing, automation, and high-throughput screening. Behavior, control, and manipulation of the fluids is geometrically constrained to a small, typically submillimeter, scale using passive fluid control techniques, such as capillary forces. Often processes which are normally carried out in a lab are miniaturized on a single chip in order to enhance efficiency and mobility, as well as reducing sample and reagent volumes.

Related Links:

Ecole Polytechnique Fédérale de Lausanne



Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunofluorescence Analyzer
MPQuanti
New
Biological Indicator Vials
BI-O.K.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.